|
1
|
Alavian SM, Fallahian F and Lankarani KB:
The changing epidemiology of viral hepatitis B in Iran. J
Gastrointestin Liver Dis. 16:403–406. 2007.PubMed/NCBI
|
|
2
|
Rehermann B and Nascimbeni M: Immunology
of hepatitis B virus and hepatitis C virus infection. Nat Rev
Immunol. 5:215–229. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Feng YL, Wang SP, Wei JN, Shi XH, Zhang
JB, Guo Q, Wu XB, Fan H and Wang XF: Comprehensive study on the
risk factors of hepatitis B virus intrauterine infection. Zhonghua
Liu Xing Bing Xue Za Zhi. 29:132–135. 2008.(In Chinese). PubMed/NCBI
|
|
4
|
Komatsu H, Inui A, Sogo T, Hiejima E,
Tateno A, Klenerman P and Fujisawa T: Cellular immunity in children
with successful immunoprophylactic treatment for mother-to-child
transmission of hepatitis B virus. BMC Infect Dis. 10:1032010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Beasley RP, Hwang LY, Lee GC, Lan CC, Roan
CH, Huang FY and Chen CL: Prevention of perinatally transmitted
hepatitis B virus infections with hepatitis B immune globulin and
hepatitis B vaccine. Lancet. 2:1099–1102. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liang YL and Fu SM: Immunity mechanism of
vertical transmission blocking for HBV immunoglobulin injection to
pregnant women. Chin J Immunol. 31:818–821. 2015.
|
|
7
|
Wang GL, Liu Y, Qiu P, Zhou SF, Xu LF, Wen
P, Wen JB and Xiao XZ: Cost-effectiveness of Lamivudine,
Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated
hepatitis B virus-related cirrhosis. Eur Rev Med Pharmacol Sci.
20:866–872. 2016.PubMed/NCBI
|
|
8
|
Han GR, Jiang HX, Yue X, Ding Y, Wang CM,
Wang GJ and Yang YF: Efficacy and safety of telbivudine treatment:
An open-label, prospective study in pregnant women for the
prevention of perinatal transmission of hepatitis B virus
infection. J Viral Hepat. 22:754–762. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lavanchy D: Hepatitis B virus
epidemiology, disease burden, treatment, and current and emerging
prevention and control measures. J Viral Hepat. 11:97–107. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luna EJ, Moraes JC, Silveira L and Salinas
HS: Efficacy and safety of the Brazilian vaccine against hepatitis
B in newborns. Rev Saude Publica. 43:1014–1020. 2009.(In
Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ko SC, Schillie SF, Walker T, Veselsky SL,
Nelson NP, Lazaroff J, Crowley S, Dusek C, Loggins K, Onye K, et
al: Hepatitis B vaccine response among infants born to hepatitis B
surface antigen-positive women. Vaccine. 32:2127–2133. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Féray C, Gigou M, Samuel D, Ducot B,
Maisonneuve P, Reynès M, Bismuth A and Bismuth H: Incidence of
hepatitis C in patients receiving different preparations of
hepatitis B immunoglobulins after liver transplantation. Ann Intern
Med. 128:810–816. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chan HL and Jia J: Chronic hepatitis B in
Asia-new insights from the past decade. J Gastroenterol Hepatol. 26
Suppl 1:131–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Raghuraman S, Park H, Osburn WO,
Winkelstein E, Edlin BR and Rehermann B: Spontaneous clearance of
chronic hepatitis C virus infection is associated with appearance
of neutralizing antibodies and reversal of T-cell exhaustion. J
Infect Dis. 205:763–771. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ellinger I, Rothe A, Grill M and Fuchs R:
Apical to basolateral transcytosis and apical recycling of
immunoglobulin G in trophoblast-derived BeWo cells: Effects of low
temperature, nocodazole, and cytochalasin D. Exp Cell Res.
269:322–331. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ellinger I, Schwab M, Stefanescu A,
Hunziker W and Fuchs R: IgG transport across trophoblast-derived
BeWo cells: A model system to study IgG transport in the placenta.
Eur J Immunol. 29:733–744. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng Y, Huang Z, Chen X, Tian Y, Tang J,
Zhang Y, Zhang X, Zhou J, Mao Q, Ni B, et al: Effects of
telbivudine treatment on the circulating CD4+ T-cell
subpopulations in chronic hepatitis B patients. Mediators Inflamm.
2012:7898592012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
von Boehmer H: Mechanisms of suppression
by suppressor T cells. Nat Immunol. 6:338–344. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jones SW, Roberts RA, Robbins GR, Perry
JL, Kai MP, Chen K, Bo T, Napier ME, Ting JP, Desimone JM, et al:
Nanoparticle clearance is governed by Th1/Th2 immunity and strain
background. J Clin Invest. 123:3061–3073. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang K, Fan X, Fan Y, Wang B, Han L and
Hou Y: Study on the function of circulating plasmacytoid dendritic
cells in the immunoactive phase of patients with chronic genotype B
and C HBV infection. J Viral Hepat. 14:276–282. 2007. View Article : Google Scholar : PubMed/NCBI
|
